INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 188 filers reported holding INOVIO PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.85 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $161,387 | -30.7% | 196,814 | +31.8% | 0.00% | – |
| Q4 2022 | $233,002 | +40.4% | 149,360 | +55.3% | 0.00% | – |
| Q3 2022 | $166,000 | -12.2% | 96,157 | -11.9% | 0.00% | – |
| Q2 2022 | $189,000 | -57.3% | 109,120 | -11.5% | 0.00% | – |
| Q1 2022 | $443,000 | -34.5% | 123,327 | -9.0% | 0.00% | – |
| Q4 2021 | $676,000 | -26.7% | 135,512 | +5.2% | 0.00% | – |
| Q3 2021 | $922,000 | -30.2% | 128,756 | -9.6% | 0.00% | -100.0% |
| Q2 2021 | $1,320,000 | -2.1% | 142,383 | -2.0% | 0.00% | 0.0% |
| Q1 2021 | $1,348,000 | +7.3% | 145,238 | +2.3% | 0.00% | 0.0% |
| Q4 2020 | $1,256,000 | +3.2% | 141,944 | +35.3% | 0.00% | 0.0% |
| Q3 2020 | $1,217,000 | -50.6% | 104,881 | +14.8% | 0.00% | -50.0% |
| Q2 2020 | $2,462,000 | +869.3% | 91,393 | +168.3% | 0.00% | – |
| Q1 2020 | $254,000 | -8.6% | 34,059 | -59.9% | 0.00% | – |
| Q4 2019 | $278,000 | +424.5% | 84,969 | +225.3% | 0.00% | – |
| Q3 2019 | $53,000 | -81.7% | 26,122 | -73.6% | 0.00% | – |
| Q2 2019 | $289,000 | -78.5% | 98,780 | -72.6% | 0.00% | -100.0% |
| Q1 2019 | $1,345,000 | +13.4% | 360,906 | +21.6% | 0.00% | 0.0% |
| Q4 2018 | $1,186,000 | -82.3% | 296,734 | -75.4% | 0.00% | -50.0% |
| Q3 2018 | $6,709,000 | +77.8% | 1,206,995 | +25.3% | 0.00% | +100.0% |
| Q2 2018 | $3,773,000 | +29.3% | 962,914 | +55.3% | 0.00% | 0.0% |
| Q1 2018 | $2,917,000 | +57.2% | 619,878 | +37.8% | 0.00% | 0.0% |
| Q4 2017 | $1,856,000 | +126.9% | 449,708 | +247.7% | 0.00% | 0.0% |
| Q3 2017 | $818,000 | +29.2% | 129,332 | +59.9% | 0.00% | – |
| Q2 2017 | $633,000 | +480.7% | 80,883 | +384.8% | 0.00% | – |
| Q1 2017 | $109,000 | -69.0% | 16,683 | -67.2% | 0.00% | – |
| Q4 2016 | $352,000 | -71.2% | 50,918 | -61.2% | 0.00% | -100.0% |
| Q3 2016 | $1,221,000 | -36.5% | 131,149 | -37.1% | 0.00% | 0.0% |
| Q2 2016 | $1,924,000 | +1573.0% | 208,399 | +1475.0% | 0.00% | – |
| Q1 2016 | $115,000 | -87.4% | 13,232 | -90.2% | 0.00% | -100.0% |
| Q4 2015 | $910,000 | +152.1% | 135,600 | +116.2% | 0.00% | – |
| Q3 2015 | $361,000 | +152.4% | 62,720 | +254.7% | 0.00% | – |
| Q2 2015 | $143,000 | +81.0% | 17,682 | +80.2% | 0.00% | – |
| Q1 2015 | $79,000 | -79.9% | 9,814 | -77.1% | 0.00% | – |
| Q4 2014 | $393,000 | +56.6% | 42,934 | +67.9% | 0.00% | – |
| Q3 2014 | $251,000 | +8266.7% | 25,567 | +8422.3% | 0.00% | – |
| Q2 2014 | $3,000 | – | 300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 648,800 | $1,920,000 | 1.55% |
| Round Table Services, LLC | 339,391 | $998,000 | 0.31% |
| ARK Investment Management | 3,955,017 | $11,628,000 | 0.29% |
| Nikko Asset Management Americas, Inc. | 4,884,100 | $14,359,000 | 0.28% |
| WASATCH ADVISORS LP | 6,735,726 | $19,803,000 | 0.19% |
| Cedar Brook Financial Partners, LLC | 41,500 | $122,000 | 0.06% |
| Unified Trust Company, N.A. | 15,716 | $46,000 | 0.03% |
| Bay Colony Advisory Group, Inc d/b/a Bay Colony Advisors | 13,500 | $40,000 | 0.03% |
| STONERIDGE INVESTMENT PARTNERS LLC | 16,914 | $50,000 | 0.02% |
| Sumitomo Mitsui Trust Holdings, Inc. | 4,884,100 | $14,359,000 | 0.01% |